(Q48498265)
Statements
1 reference
Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model. (English)
1 reference
1 reference
Yoshikazu Tasaki
1 reference
Joe Yamamoto
1 reference
Tomohiro Omura
1 reference
Tomoki Sakaguchi
1 reference
Norihisa Kimura
1 reference
Ko-Ichi Ohtaki
1 reference
Takashi Ono
1 reference
Masaru Asari
1 reference
Tomoko Ohkubo
1 reference
Toshihiro Noda
1 reference
Toshio Awaya
1 reference
Keiko Shimizu
1 reference
Kazuo Matsubara
1 reference
19 May 2012
1 reference
1 reference
521
1 reference
1
1 reference
15-19
1 reference